Nathan Boersen

City:

Summit, New Jersey

Country:

United States

Published Applications:

Last publication date:

2018-02-15

Top Assignees for applications by Nathan Boersen

The entities that hold a legal rights for patent applications filed by inventor Boersen Nathan:

Signal Pharmaceuticals, LLC 6 San Diego, CA United States

Recent patent applications by Boersen Nathan

Nathan Boersen from Summit, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-02-15

US20180042924A1

Human necessities

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

#2 | 2016-11-03

US20160318940A1

Chemistry; metallurgy

Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one as TOR kinase inhibitors

#3 | 2016-09-01

US20160250210A1

Human necessities

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

#4 | 2015-10-22

US20150299209A1

Chemistry; metallurgy

Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, as TOR kinase inhibitors

#5 | 2014-10-23

US20140315908A1

Chemistry; metallurgy

Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one

#6 | 2013-06-06

US20130142873A1

Chemistry; metallurgy

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-]pyrazin-2(1)-one, a solid form thereof and methods of their use

InventorID:

945803 ⎘